Use of hemospray for non-variceal esophageal bleeding in an infant

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
A: Esophageal varices: Upper endoscopy demonstrates four columns of esophageal varices. A consequence of portal hypertension, esophageal varices are one.
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Primary prevention of variceal haemorrhage: A pharmacological approach
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
The place of downstaging for hepatocellular carcinoma
Yoji Ishizu, MD, PhD, Masatoshi Ishigami, MD, PhD 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 41, Issue 4, Pages (October 2004)
The changing role of beta-blocker therapy in patients with cirrhosis
Reply to: “It takes two “eyes” to see in depth”
Volume 65, Issue 2, Pages (August 2016)
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Massive small-bowel bleeding treated with hemostatic powder
The impact of intestinal microflora on serum bilirubin levels
Esophageal variceal bleeding: Primary prophylaxis
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?  James J. Farrell, MD  Gastrointestinal Endoscopy 
The use of hemospray in portal hypertensive bleeding; a case series
Chronic hepatitis B in children and adolescents
Volume 66, Issue 4, Pages (April 2017)
Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?  Jingzhi Cai, Wengang Guo, Chuangye.
New trials and results in systemic treatment of HCC
Liver transplantation in children
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Results of six hundred thirty-six esophageal transections with paraesophagogastric devascularization in the treatment of esophageal varices  Mitsuo Sugiura,
Volume 50, Issue 1, Pages 4-6 (January 2009)
Genetics of hepatocellular carcinoma: The next generation
MELD: the holy grail of organ allocation?
A. C. Malbrunot-Wagner, L. Bridoux, J. B. Nousbaum, C. Riou, A
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Clinical microbiological case: esophageal lesion in an aids patient
Presentation transcript:

Use of hemospray for non-variceal esophageal bleeding in an infant Massimiliano Paganelli, Fernando Alvarez, Ugur Halac  Journal of Hepatology  Volume 61, Issue 3, Pages 712-713 (September 2014) DOI: 10.1016/j.jhep.2014.05.002 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Upper gastrointestinal endoscopy images of the case described. Upper gastrointestinal endoscopy performed in the patient at diagnosis (A) shows grade II and III varices with red wales and spots. A large actively bleeding esophageal ulcer was visualized 11days post-sclerotherapy (B). Hemospray allowed to stop the active bleeding from the ulcer (C). The healing of the ulcer was noted 6days from the procedure (D). Journal of Hepatology 2014 61, 712-713DOI: (10.1016/j.jhep.2014.05.002) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions